HCPCS Level IIdrugActive
J1454
Inj fosnetupitant, palonoset
BETOS: O1E
Effective: 2019-01-01
Referenced in 2 policies
Description
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Akynzeo
Manufacturer
Helsinn Therapeutics (U.S.), Inc.
HCPCS Dosage
0.25 MG
Billing Units
1.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.